Investigation of the Th1 immune response in sarcoidosis CD4 T cells has revealed reduced proliferative capacity and cytokine expression upon TCR stimulation. In other disease models, such cellular dysfunction has been associated with a step-wise, progressive loss of T cell function that results from chronic antigenic stimulation. T cell exhaustion is defined by decreased cytokine production upon TCR activation, decreased proliferation, increased expression of inhibitory cell surface receptors, and increased susceptibility to apoptosis. We characterized sarcoidosis CD4 T cell immune function in systemic and local environments among subjects undergoing disease progression compared to those experiencing disease resolution. Spontaneous and TCR-stimulated Th1 cytokine expression and proliferation assays were performed in 53 sarcoidosis subjects and 30 healthy controls. PD-1 expression and apoptosis were assessed by flow cytometry. Compared to healthy controls, sarcoidosis CD4 T cells demonstrated reductions in Th1 cytokine expression, proliferative capacity ( < 0.05), enhanced apoptosis ( < 0.01), and increased PD-1 expression ( < 0.001). BAL-derived CD4 T cells also demonstrated multiple facets of T cell exhaustion ( < 0.05). Reversal of CD4 T cell exhaustion was observed in subjects undergoing spontaneous resolution ( < 0.05). Sarcoidosis CD4 T cells exhibit loss of cellular function during progressive disease that follows the archetype of T cell exhaustion.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5695030PMC
http://dx.doi.org/10.1155/2017/3642832DOI Listing

Publication Analysis

Top Keywords

cell exhaustion
20
sarcoidosis cd4
16
cd4 cells
16
cd4 cell
12
cytokine expression
12
cell
8
proliferative capacity
8
subjects undergoing
8
th1 cytokine
8
healthy controls
8

Similar Publications

SLAMF7 defines subsets of human effector CD8 T cells.

Sci Rep

December 2024

Singapore Immunology Network (SIgN), Agency for Science Technology and Research (A*STAR), Immunos Building, 8A Biomedical Grove, Biopolis, Republic of Singapore.

Long-term control of viral replication relies on the efficient differentiation of memory T cells into effector T cells during secondary immune responses. Recent findings have identified T cell precursors for both memory and exhausted T cells, suggesting the existence of progenitor-like effector T cells. These cells can persist without antigenic challenge but expand and acquire effector functions upon recall immune responses.

View Article and Find Full Text PDF

Haematological deterioration of Hematodinium-infected decapod crustaceans.

Dev Comp Immunol

December 2024

Zoology and Ryan Institute, School of Natural Sciences, University of Galway, Galway H91 TK33, Ireland. Electronic address:

Parasitic dinoflagellates, namely Hematodinium spp., infect a growing number of decapod crustacean species worldwide. These parasites represent a longstanding concern for fisheries in Europe and North America, and an emerging concern for aqua/polyculture systems in Asia.

View Article and Find Full Text PDF

Targeting P4HA1 promotes CD8 T cell progenitor expansion toward immune memory and systemic anti-tumor immunity.

Cancer Cell

December 2024

Genome Institute of Singapore, Agency for Science, Technology, and Research (A(∗)STAR), 60 Biopolis Street, Singapore; Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Cancer and Stem Cell Biology, Duke-NUS Medical School, Singapore. Electronic address:

Successful immunotherapy relies on both intratumoral and systemic immunity, which is yet to be achieved for most patients with cancer. Here, we identify P4HA1, encoding prolyl 4-hydroxylase 1, as a crucial regulator of CD8 T cell differentiation strongly upregulated in tumor-draining lymph nodes (TDLNs) and hypoxic tumor microenvironment. P4HA1 accumulates in mitochondria, disrupting the tricarboxylic acid (TCA) cycle through aberrant α-ketoglutarate and succinate metabolism, promoting mitochondria unfitness and exhaustion while suppressing progenitor expansion.

View Article and Find Full Text PDF

Hyperreactive B cells instruct their elimination by T cells to curb autoinflammation and lymphomagenesis.

Immunity

December 2024

Institute of Experimental Hematology, School of Medicine, Technical University of Munich, 81675 Munich, Germany; Center for Translational Cancer Research (TranslaTUM), School of Medicine, Technical University of Munich, 81675 Munich, Germany; German Cancer Consortium (DKTK), 69120 Heidelberg, Germany; Max-Planck Institute of Biochemistry, 82152 Planegg, Germany. Electronic address:

B cell immunity carries the inherent risk of deviating into autoimmunity and malignancy, which are both strongly associated with genetic variants or alterations that increase immune signaling. Here, we investigated the interplay of autoimmunity and lymphoma risk factors centered around the archetypal negative immune regulator TNFAIP3/A20 in mice. Counterintuitively, B cells with moderately elevated sensitivity to stimulation caused fatal autoimmune pathology, while those with high sensitivity did not.

View Article and Find Full Text PDF

Galectin-3 secreted by triple-negative breast cancer cells regulates T cell function.

Neoplasia

December 2024

Felsenstein Medical Research Center, Beilinson Campus, Petah Tikva, Israel; Tel Aviv University, Faculty of Medicine and Health Sciences, Tel Aviv, Israel; Rabin Medical Center, Beilinson Campus, Petah Tikva, Israel; Davidoff Cancer Center, Beilinson Campus, Petah Tikva, Israel. Electronic address:

Triple-negative breast cancer (TNBC) is an aggressive subtype that accounts for 10-15 % of breast cancer. Current treatment of high-risk early-stage TNBC includes neoadjuvant chemo-immune therapy. However, the substantial variation in immune response prompts an urgent need for new immune-targeting agents.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!